@VanderbiltMSTP student interested in inflammation in cardiovascular disease. Longhorns, Mavs, film, and music.

Joined July 2011
Photos and videos
Duncan Smart PhD retweeted
18 Feb 2024
Single subcutaneous doses of zilebesiran significantly lower blood pressure for up to 6 months, suggesting potential for use as an effective antihypertensive with quarterly or biannual dosing. Read the KARDIA-1 RCT: ja.ma/48jbBAy
7
71
203
51,559
Duncan Smart PhD retweeted
Looking forward to working with @MichaelR21 @JeffHsuMD and @VasRes to learn about all the exciting translational work coming out of #JACCBTS!
Replying to @MichaelR21
11/11 To cap the thread off on a personal note, I am excited to join the #JACCBTS team as a Social Media Consultant along with @Jean_Wassenaar! Follow us for more tweetorials on future articles from the journal! @JeffHsu @VascRes
4
7
1,293
Duncan Smart PhD retweeted
Excited to join the #JACCBTS social media team—it has quickly become a journal in which to find and publish high-quality cardiovascular research. Follow the entire team for more great work published in #JACCBTS! @JeffHsuMD @VascRes @Jean_Wassenaar @JACCJournals
We still have no medical therapy for aortic stenosis, but in this month’s issue of @JACCJournals #JACCBTS, Han, et al. take us closer to possible pharmacologic targets as they define the role of PALMD in aortic valve disease. 🎯 Come along as we take a look! 🧵 1/11
4
17
3,938
Duncan Smart PhD retweeted
When Einthoven introduced the ECG to the world, he uniquely labeled its parts PQRST, inspired by mathematicians who used Ps & Qs in coordinates. Yet, he believed there was more to find, so he started in the alphabet's middle, leaving room for new discoveries on both sides. 1/n
9
135
594
139,911
Woah. CCR2 myeloid cell imaging in the human heart. Can’t wait to see this applied more broadly in CV diseases. Amazing work from Lavine at al. Great example of translating mechanistic preclinical findings to humans
RESEARCH| Lavine et al. establish the feasibility of C-C chemokine receptor 2 (#CCR2) #imaging, a marker of inflammatory monocytes/macrophages, in patients that suffered a #MyocardialInfarction| @LavineLab, Yongjian Liu, @WUSTL nature.com/articles/s44161-0… 👉rdcu.be/dmYvv
1
7
874
Duncan Smart PhD retweeted
29 Aug 2023
Cardiometabolic Effects of DOCA-salt in Mice Depend on Ambient Temperature @JLGrobe @fekete2003 @nakagawapablo @curtsigmund ahajrnls.org/45tWDH0
8
17
2,956
Duncan Smart PhD retweeted
Celebrating our transitions and next steps #Madhur Lab #Alexander Lab #WillMissThisGang!! ⁦@DJFehrenbach⁩ ⁦@smartdunc⁩ ⁦@Jean_Wassenaar⁩ ⁦@VascRes⁩ ⁦@VUMC_MedPSTP⁩ ⁦@VUMC_Medicine⁩ ⁦@VUMCClinPharm⁩ #GreenHillsGrille
4
34
2,394
Duncan Smart PhD retweeted
First oral semaglutide made a strong impression in OASIS-1 #obesity with 15% #weightloss now orforglipron leads the impressive pack of new small molecule oral GLP-1RA with robust #Weightloss and good tolerability ADA2023
3
55
212
67,265
Many thanks to all my coauthors who made this possible! Excited to share this story in its final form
Replying to @smartdunc
@smartdunc's first first-author paper is finally in press! @CVResearch "Immune profiling of murine cardiac leukocytes identifies Trem2 as a novel mediator of hypertensive heart failure" shorturl.at/gG123 @CVimmunology @Jean_Wassenaar @AmandaDoranLab @VAgrawalMDPhD
4
21
1,648
Duncan Smart PhD retweeted
Join us in one week as @ThaoDVLe, graduate student in the lab of Julio Ayala (@TheBurro34), defends her thesis titled "Identification of Intracellular and Physiological Targets Transducing the Weight-Lowering Actions of Glucagon-Like Peptide 1 Receptor Agonists!" @VanderbiltMSTP
1
5
21
4,685
Excited to see this officially out!
2
8
936
Duncan Smart PhD retweeted
Hypertension is the leading modifiable risk factor for worldwide morbidity & mortality. This study describes the role of T cells in hypertension & hypertensive end-organ damage & outlines potential therapeutic targets bit.ly/KID090 @DJFehrenbach @VascRes @CVimmunology
1
16
29
9,083
Excited to share a portion of my thesis work soon! For those who can’t attend in person, please reach out and I will share a zoom link!
In two weeks @smartdunc, a graduate student in the lab of Meena Madhur, will defend his thesis titled "Inflammation in hypertensive cardiac remodeling and heart failure." We can't wait to see you there and here all about this work!
3
2
33
3,530
Duncan Smart PhD retweeted
1/ We are delighted to see our study on the effect of sucralose on T-cells was published today in @Nature! Time for a tweetorial 🧐 (with GIFs 🤠)
A study in @Nature finds that high doses of the sweetener sucralose reduce immune responses in mice. The findings do not provide evidence that normal sucralose intake may be immunosuppressive. go.nature.com/42fnJ3p
16
83
460
253,258
Duncan Smart PhD retweeted
21 Dec 2022
#OriginalResearch: In a meta-analysis of 8 studies, 6,000 to 9,000 steps/day was associated with 40% to 50% lower risk of CVD among older adults #AHAJournals ahajrnls.org/3WgtECd
1
48
136
100,295
Duncan Smart PhD retweeted
The median time of onset of ICI-myocarditis is ~30-60 days In our patient, it occurred at 987 days We report a case of fulminant late onset ICI-myocarditis. Hoping to raise awareness for late onset irAEs @HanZhuMD @SeanM_Wu @Ron_Witteles @JACCJournals jacc.org/doi/10.1016/j.jacca…
2
9
64
11,685
Duncan Smart PhD retweeted
Thanks @nanostringtech for selecting me for the grant, can’t wait to use the CVD pathophysiology panels to advance my research!
👏 to our North America nCounter CVD Pathophysiology Panel Grant Program Winners: Jean Wassenaar, MD Ph.D. of @VanderbiltU Medical Center & Steven Goldman, Ph.D. of @uarizona Sarver Heart Center. Check out this Brief nCounter with the CVD Panel 👉 bit.ly/3WcDogk
3
2
30
Duncan Smart PhD retweeted
Amazing CV Research Day celebration @VUMC_heart with @alan_daugherty giving keynote address. Congrats @AzuahTheShort in @AmandaDoranLab for best student abstract. Record turnout to promote cardiovascular science @VUMCResearch.
4
16